This move is archived. Current quotes and coverage live on the stock page.
Follow TELY
TelyRx Holdings Inc. has seen a remarkable surge in its stock price, gaining over 13% in just one trading day.
In the latest trading session, TelyRx Holdings Inc. (TELY.TO) experienced a significant boost, closing at CA$2.50, marking a 13.64% increase. This surge is linked to the company's upcoming presentation at a key investor conference, which has sparked renewed interest among investors.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$59.30M
52W high
$4.25
52W low
$2.00
1W change
+0.00%
Analyst Price Targets
Based on analyst covering TELY · as of Sep 17, 2026
Wall Street analysts forecast TELY stock price to rise 166.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+166.7% Upside
Current Price
C$2.25
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
69.2%
Annualized
90-Day Vol
95.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.88
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.12 | C$1.67 – C$2.69 |
| 60 trading days | C$2.00 | C$1.43 – C$2.80 |
| 90 trading days | C$1.88 | C$1.24 – C$2.85 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Keep an eye on TelyRx's upcoming conference presentation. It may provide valuable insights into the company's growth strategy and potential market opportunities.
TelyRx Holdings Inc. Gains 13.64% in One Day
The stock's market cap now stands at approximately CA$58.47 million, reflecting growing investor confidence.
Bull case
The upcoming Small Cap Growth Virtual Investor Conference is expected to draw significant investor attention. This could lead to more buying and further increases in the stock price.
Bear case
Despite the positive momentum, TelyRx's lack of profitability and high volatility could pose risks for investors, especially if the conference does not meet expectations.
Advertisement
Key Drivers of the Stock Surge
TelyRx's stock price increase is largely due to its participation in the Small Cap Growth Virtual Investor Conference. This event offers the company a chance to showcase its innovative digital pharmacy platform and engage directly with investors, which could lead to increased interest and investment in the company.
Market Reaction and Future Outlook
The market's positive response to TelyRx's news reflects a broader interest in healthcare technology stocks, particularly those that make accessing medications easier. However, investors should stay cautious, as the company's current financial metrics, including a negative profit margin, show that it is still in the early stages of its growth journey. Watching the outcomes of the conference will be crucial for assessing future performance.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
